Business Description
ReproCELL Incorp
ISIN : JP3974770004
Description
ReproCELL Incorp is one of the leading stem cell research company in Japan. The company provides stem cell services, predictive drug discovery services, tissue services, and molecular services.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.93 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 9.19 | |||||
| Beneish M-Score | -2.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.3 | |||||
| 3-Year FCF Growth Rate | 38 | |||||
| 3-Year Book Growth Rate | 7.5 | |||||
| Future 3-5Y Total Revenue Growth Rate | 12.98 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.84 | |||||
| 9-Day RSI | 44.71 | |||||
| 14-Day RSI | 42.06 | |||||
| 6-1 Month Momentum % | -15.83 | |||||
| 12-1 Month Momentum % | -29.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.4 | |||||
| Quick Ratio | 8.97 | |||||
| Cash Ratio | 8.04 | |||||
| Days Inventory | 74.37 | |||||
| Days Sales Outstanding | 53.11 | |||||
| Days Payable | 39.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.5 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.1 | |||||
| Operating Margin % | -12.19 | |||||
| Net Margin % | -7.56 | |||||
| FCF Margin % | -7.84 | |||||
| ROE % | -2.42 | |||||
| ROA % | -2.23 | |||||
| ROIC % | -11.43 | |||||
| ROC (Joel Greenblatt) % | 18.59 | |||||
| ROCE % | 0.78 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 128.75 | |||||
| PS Ratio | 3.44 | |||||
| PB Ratio | 1.09 | |||||
| Price-to-Tangible-Book | 1.11 | |||||
| EV-to-EBIT | 60.4 | |||||
| EV-to-EBITDA | 44.98 | |||||
| EV-to-Revenue | 1.48 | |||||
| EV-to-FCF | -17.43 | |||||
| Price-to-Median-PS-Value | 0.21 | |||||
| Price-to-Net-Current-Asset-Value | 1.81 | |||||
| Price-to-Net-Cash | 2.16 | |||||
| Earnings Yield (Greenblatt) % | 1.65 | |||||
| FCF Yield % | -2.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ReproCELL Incorp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 2,600.091 | ||
| EPS (TTM) (円) | -2.227 | ||
| Beta | 0.83 | ||
| Volatility % | 28.47 | ||
| 14-Day RSI | 42.06 | ||
| 14-Day ATR (円) | 3.504825 | ||
| 20-Day SMA (円) | 105.05 | ||
| 12-1 Month Momentum % | -29.52 | ||
| 52-Week Range (円) | 97 - 180 | ||
| Shares Outstanding (Mil) | 94.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ReproCELL Incorp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ReproCELL Incorp Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
ReproCELL Incorp Frequently Asked Questions
What is ReproCELL Incorp(TSE:4978)'s stock price today?
The current price of TSE:4978 is 円103.00. The 52 week high of TSE:4978 is 円180.00 and 52 week low is 円97.00.
When is next earnings date of ReproCELL Incorp(TSE:4978)?
The next earnings date of ReproCELL Incorp(TSE:4978) is .
Does ReproCELL Incorp(TSE:4978) pay dividends? If so, how much?
ReproCELL Incorp(TSE:4978) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers